The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study

References

• WeinrebRNAungTMedeirosFAThe pathophysiology and treatment of glaucoma: a reviewJAMA2014311181901191124825645
   PubMed Web of Science ®Google Scholar
• IwaseAAraieMTomidokoroAYamamotoTShimizuHKitazawaYTajimi Study GroupPrevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi StudyOphthalmology200611381354136316877074
   PubMed Web of Science ®Google Scholar
• KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol2002120670171312049574
   PubMed Web of Science ®Google Scholar
• HigginbothamEJConsiderations in glaucoma therapy: fixed combinations versus their component medicationsClin Ophthalmol201041920169043
   PubMedGoogle Scholar
• KuwayamaYDE-111 Collaborative Trial GroupPhase III double-masked study of fixed combination tafluprost 0.0015%/timolol 0.5% (DE-111) versus tafluprost 0.0015% alone or given concomitantly with timolol 0.5% in primary open angle glaucoma and ocular hypertensionAtarashii Ganka201332811851194 Japanese
   Google Scholar
• KuwayamaYDE-111 Collaborative Trial GroupA long-term, open-label study of fixed combination tafluprost 0.0015%/timolol 0.5% (DE-111) in patients with open-angle glaucoma or ocular hypertensionAtarashii Ganka2015321133143 Japanese
   Google Scholar
• RamliNSupramaniamGSamsudinAJuanaAZahariMChooMMOcular surface disease in glaucoma: effect of polypharmacy and preservativesOptom Vis Sci2015929e222e22625730335
   PubMed Web of Science ®Google Scholar
• UzunosmanogluEMocanMCKocabeyogluSKarakayaJIrkecMMeibomian gland dysfunction in patients receiving long-term glaucoma medicationsCornea20163581112111627055218
   PubMed Web of Science ®Google Scholar
• BaudouinCLabbéALiangHPaulyABrignole-BaudouinFPreservatives in eyedrops: the good, the bad and the uglyProg Retin Eye Res201029431233420302969
   PubMed Web of Science ®Google Scholar
• KumagamiTWakiyamaHKusanoMComparison of corneal safety and intraocular pressure-lowering effect of tafluprost ophthalmic solution with other prostaglandin ophthalmic solutionsJ Ocul Pharmacol Ther201430434034524576066
   PubMed Web of Science ®Google Scholar
• LeeSKimMKChoiHJWeeWRKimDMComparative cross-sectional analysis of the effects of topical antiglaucoma drugs on the ocular surfaceAdv Ther201330442042923564224
   PubMed Web of Science ®Google Scholar
• KanamotoTKiuchiYTanitoMComparison of the toxicity profile of benzalkonium chloride-preserved tafluprost and SofZia-preserved travoprost applied to the ocular surfaceJ Ocul Pharmacol Ther201531315616425710276
   PubMed Web of Science ®Google Scholar
• TakagiYOsakiHYamashitaTKaiYProspective observational post-marketing study of tafluprost 0.0015%/timolol 0.5% combination ophthalmic solution for glaucoma and ocular hypertension: short-term efficacy and safetyOphthalmol Ther20165219120627492380
   PubMed Web of Science ®Google Scholar
• PaulyARoubeixCLiangHBrignole-BaudouinFBaudouinCIn vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulationInvestig Ophthalmol Vis Sci201253138172818023150620
   PubMed Web of Science ®Google Scholar
• AiharaMOshimaHAraieMEXTraKT study groupEffects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface – a multicentre randomized single-masked studyActa Ophthalmol2013911e7e1423241328
   PubMed Web of Science ®Google Scholar
• WeissmanSSAsbellPAEffects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivityBr J Ophthalmol19907474094122378856
   PubMed Web of Science ®Google Scholar
• Aydin KurnaSAcikgozSAltunAOzbayNSengorTOlcaysuOOThe effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective studyJ Ophthalmol2014201446048325009742
   PubMed Web of Science ®Google Scholar
• NagaiNMuraoTOeKItoYOkamotoNShimomuraYIn vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)Yakugaku Zasshi20111316985991 Japanese21628988
   PubMed Web of Science ®Google Scholar
• FuwaMUedaKAkaishiTAdvantages of efficacy and safety of fixed-dose tafluprost/timolol combination over fixed-dose latanoprost/timolol combinationPLoS One2016117e015879727383260
   PubMed Web of Science ®Google Scholar
• KashiwagiKEfficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapyJpn J Ophthalmol201256433934522581454
   PubMed Web of Science ®Google Scholar
• SuzukiKTeranishiSSagaraTSafety and efficacy of benzalkonium chloride-optimized tafluprost in Japanese glaucoma patients with existing superficial punctate keratitisJ Glaucoma2015246e145e15024240881
   PubMed Web of Science ®Google Scholar
• AritaRItohKMaedaSEffects of long-term topical anti-glaucoma medications on meibomian glandsGraefes Arch Clin Exp Ophthalmol201225081181118522349978
   PubMed Web of Science ®Google Scholar
• ZimmermanTJHahnSRGelbLTanHKimEEThe impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistenceJ Ocul Pharmacol Ther200925214515219284321
   PubMed Web of Science ®Google Scholar
• YanagiMKiuchiYYuasaYAssociation between glaucoma eye drops and hyperemiaJpn J Ophthalmol2016602727726847553
   PubMed Web of Science ®Google Scholar
• QuarantaLBiagioliERivaIProstaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysisJ Ocul Pharmacol Ther201329438238923231442
   PubMed Web of Science ®Google Scholar
• RadcliffeNMThe impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapiesClin Ophthalmol201482541254925540579
   PubMedGoogle Scholar
• DicksteinKHapnesRAarslandTComparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucomaAm J Ophthalmol2001132562663211704023
   PubMed Web of Science ®Google Scholar
• FukuchiYNishimuraMIchinoseMCOPD in Japan: the Nippon COPD Epidemiology studyRespirology20049445846515612956
   PubMed Web of Science ®Google Scholar